REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 19 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $316,000 | +222.4% | 619,389 | +489.3% | 0.00% | – |
| Q4 2018 | $98,000 | +276.9% | 105,100 | +500.9% | 0.00% | – |
| Q2 2018 | $26,000 | 0.0% | 17,489 | 0.0% | 0.00% | – |
| Q1 2018 | $26,000 | -43.5% | 17,489 | -22.5% | 0.00% | – |
| Q4 2017 | $46,000 | -94.5% | 22,569 | -93.4% | 0.00% | -100.0% |
| Q3 2017 | $833,000 | -42.4% | 344,299 | -31.9% | 0.00% | -50.0% |
| Q2 2017 | $1,445,000 | – | 505,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 169,901 | $411,000 | 0.03% |
| Benin Management CORP | 14,300 | $35,000 | 0.01% |
| Northeast Financial Consultants Inc | 15,000 | $36,000 | 0.01% |
| WEDBUSH SECURITIES INC | 25,500 | $62,000 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 49,167 | $119,000 | 0.00% |
| Renaissance Technologies | 344,299 | $833,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,238 | $20,000 | 0.00% |
| NORTHERN TRUST CORP | 47,859 | $116,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 28 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 146,083 | $353,000 | 0.00% |